---

---

symbols : NVSEF    crawled time : 16:00   

save search

---

9.18% CAGR growth in Cancer Biologics Market by Product (Monoclonal antibodies, Cell and gene therapy, vaccines, and others), Route Of Administration, and Geography- Global forecast to 2028
Published: 2024-02-19 (Crawled : 16:00) - prnewswire.com
BIIB | $194.39 2.03% 1.99% 1.6M |

Health Technology

| Email alert Add to watchlist
VTRS | $11.25 1.17% 1.16% 4.7M |

Health Technology

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K |

Health Technology

| Email alert Add to watchlist
AZN | $68.56 0.29% 0.29% 4.7M |

Health Technology

| Email alert Add to watchlist
GLAXF | $20.2 -14.18% 510 |

Health Technology

| Email alert Add to watchlist
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| Email alert Add to watchlist
AZNCF | $138.24 -4.19% 800 |

Health Technology

| Email alert Add to watchlist
JAZZ | $109.96 0.63% 0.63% 760K |

Health Technology

| Email alert Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| Email alert Add to watchlist
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| Email alert Add to watchlist
cancer cell global growth market

---

Genmab Publishes 2023 Annual Report
Published: 2024-02-14 (Crawled : 16:00) - globenewswire.com
GNMSF | $290.38 3.83% 220 |

Health Technology

| 7.15% | O: 2.65% H: 4.56% C: 1.23%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -6.04% | O: -0.02% H: 0.24% C: 0.01%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -8.08% | O: -0.91% H: 0.0% C: 0.0%
GMAB | $28.72 1.38% 1.36% 360K |

Health Technology

| 7.95% | O: 1.32% H: 5.34% C: 3.02%
report

---

Antibacterial Drugs Market Report 2024-2034, Featuring Profiles of AbbVie, AstraZeneca, Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer & Sanofi
Published: 2024-01-26 (Crawled : 16:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 2.46% | O: -1.67% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -6.6% | O: 1.8% H: 0.0% C: -1.82%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -13.0% | O: 0.29% H: 0.15% C: -0.13%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -8.89% | O: 0.8% H: 0.0% C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 1.96% | O: 1.36% H: 0.23% C: -0.76%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -2.64% | O: 0.71% H: 0.48% C: -0.52%
ABBV | News | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 0.76% | O: 0.85% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -8.8% | O: 0.5% H: 0.0% C: 0.0%
report antibacterial sanofi market

---

Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions - December 8, 2023
Published: 2023-12-08 (Crawled : 16:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -3.34% | O: -1.29% H: 0.4% C: 0.4%
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -11.21% | O: 0.07% H: 1.1% C: 0.45%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -2.97% | O: 0.19% H: 0.35% C: 0.2%
kisqali breast risk novartis

---

Novartis data show potential of remibrutinib as an oral treatment for chronic spontaneous urticaria providing significant symptom improvement as early as Week 2
Published: 2023-11-09 (Crawled : 16:00) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -1.38% | O: -0.26% H: 0.04% C: -0.96%
urticaria treatment novartis week potential show

---

Genmab Announces Financial Results for the First Nine Months of 2023
Published: 2023-11-07 (Crawled : 16:00) - globenewswire.com
GNMSF | $290.38 3.83% 220 |

Health Technology

| -1.5% | O: 0.39% H: 4.92% C: 1.52%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -0.4% | O: 0.24% H: 0.18% C: 0.16%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -4.43% | O: 0.18% H: 0.0% C: 0.0%
ABBV | News | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 16.48% | O: -0.28% H: 0.0% C: 0.0%
GMAB | $28.72 1.38% 1.36% 360K |

Health Technology

| -1.11% | O: 0.24% H: 3.44% C: 2.07%
BNTX | $86.82 0.75% 0.75% 1.6M |

Health Technology

| -13.58% | O: -0.35% H: 3.09% C: 3.03%
financial results

---

Growing Geriatric Population Fuels Ankylosing Spondylitis Market: Management of Pain and Mobility Gains Importance in Aging Demographics
Published: 2023-10-13 (Crawled : 16:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K |

Health Technology

| -28.12% | O: -1.86% H: 0.0% C: 0.0%
ALPMY | $9.47 -1.11% 520K |

Manufacturing

| -30.76% | O: -2.78% H: 0.04% C: -0.57%
VTRS | $11.25 1.17% 1.16% 4.7M |

Health Technology

| 17.55% | O: -0.21% H: 0.42% C: -1.17%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -4.89% | O: -0.55% H: 0.69% C: -0.09%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -6.93% | O: 0.64% H: 0.0% C: 0.0%
LLY | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 23.38% | O: 1.15% H: 0.0% C: 0.0%
ABBV | News | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 11.37% | O: 0.38% H: 0.0% C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 0.23% | O: -0.59% H: 0.62% C: -0.56%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| -7.05% | O: 0.93% H: 0.26% C: -1.25%
management growing

---

Healthcare at Your Fingertips: Global Mobile Medical Apps Market Skyrockets
Published: 2023-09-29 (Crawled : 16:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -9.04% | O: 1.18% H: 0.06% C: -1.62%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -16.92% | O: 0.07% H: 0.48% C: -0.24%
BSX | $67.33 -0.13% -0.31% 7M |

Health Technology

| 26.33% | O: 0.17% H: 0.0% C: -1.23%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| 8.44% | O: 0.31% H: 0.0% C: 0.0%
CSCO | News | $48.33 0.46% 0.46% 20M |

Technology Services

| -10.47% | O: 0.52% H: 0.07% C: -0.74%
BEAT | $2.02 -3.35% -3.47% 79K |

Health Technology

| -11.76% | O: 7.84% H: 0.9% C: -2.27%
MDRX | $7.55 -5.66% 440K |

Technology Services

| -43.57% | O: 0.07% H: 0.0% C: -1.87%
global medical mobile market

---

Global Orphan Drugs Market Analysis Report 2023: A 229.71 Billion Market by 2026 - Therapeutic Versatility and the Impacts on Oncology, Hematology, and More
Published: 2023-09-15 (Crawled : 16:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 13.36% | O: 3.82% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 10.49% | O: 0.79% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -8.59% | O: 1.51% H: 0.26% C: -0.72%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -11.48% | O: 0.15% H: 0.51% C: -1.54%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 5.91% | O: 0.83% H: 0.27% C: -0.72%
LLY | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 26.9% | O: 0.08% H: 0.0% C: 0.0%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -18.81% | O: -0.08% H: 0.65% C: -0.69%
ABBV | News | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 7.5% | O: -0.64% H: 0.0% C: 0.0%
report global market

---

Decoding the Global Vasectomy Market 2023: Trends, Strategies, and Regulatory Insights
Published: 2023-09-04 (Crawled : 16:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| Email alert Add to watchlist
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| Email alert Add to watchlist
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K |

Health Technology

| Email alert Add to watchlist
ENDP | $0.2926 -9.6% |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| Email alert Add to watchlist
ABBV | News | $166.41 1.06% 0.0% 5.5M |

Health Technology

| Email alert Add to watchlist
GLAXF | $20.2 -14.18% 510 |

Health Technology

| Email alert Add to watchlist
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| Email alert Add to watchlist
ENDPQ | $0.0006 -50.0% 3.4K |

n/a

| Email alert Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| Email alert Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| Email alert Add to watchlist
TEVJF | $12.37 -24.22% 380 |

Health Technology

| Email alert Add to watchlist
global market

---

Global Diabetes Drugs Market to Reach $106.65 Billion by 2028: Rising Prevalence of Diabetes Fuels Growth
Published: 2023-08-21 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -13.9% | O: -0.02% H: 0.0% C: 0.0%
AZNCF | $138.24 -4.19% 800 |

Health Technology

| -0.53% | O: 0.16% H: 0.51% C: 0.51%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -7.86% | O: 1.5% H: 0.52% C: 0.43%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -16.39% | O: -2.16% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -14.31% | O: 1.17% H: 0.0% C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M |

Health Technology

| -0.28% | O: 0.76% H: 0.23% C: -0.14%
reach global diabetes growth market

---

Novartis to feature new PNH and CML scientific data from broad hematology portfolio at European Hematology Association Annual Meeting
Published: 2023-05-11 (Crawled : 16:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 8.88% | O: 0.92% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -10.18% | O: -0.4% H: 0.34% C: 0.19%
association meeting novartis

---

Type 2 diabetes market size to increase by USD 39.37 billion between 2022 and 2027; Growth driven by increasing prevalence of diabetes - Technavio
Published: 2023-03-03 (Crawled : 16:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 17.61% | O: 0.09% H: 1.57% C: 1.51%
AZNCF | $138.24 -4.19% 800 |

Health Technology

| 2.85% | O: -1.0% H: 0.73% C: -0.19%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 36.1% | O: 0.99% H: 0.0% C: -0.1%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 9.35% | O: -0.55% H: 0.27% C: 0.04%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 14.52% | O: -0.38% H: 0.65% C: 0.61%
BAX | $39.47 -0.45% 0.0% 2.8M |

Health Technology

| 0.2% | O: 1.11% H: 0.67% C: -0.3%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -4.45% | O: -0.46% H: 0.0% C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 4.86% | O: -0.61% H: 0.8% C: 0.77%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 12.86% | O: 0.11% H: 0.38% C: -0.08%
diabetes growth market

---

Alimera Appoints Roger Sawhney, M.D. to Its Board of Directors
Published: 2023-02-27 (Crawled : 16:00) - biospace.com/
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 8.71% | O: 0.64% H: 0.01% C: -0.72%
KKR | $92.62 -0.78% 0.0% 4.5M |

Finance

| 71.96% | O: 1.6% H: 0.75% C: -0.47%
ALIM | $3.41 -0.87% -0.88% 48K |

Health Technology

| 58.76% | O: 0.22% H: 1.98% C: -2.25%

---

Opioid Induced Constipation (OIC) Drugs Market to Reach USD 1.79 billion, Globally, by 2031 at 4.9% CAGR: Allied Market Research
Published: 2023-02-24 (Crawled : 16:00) - prnewswire.com
MNK | $0.3402 -0.06% 540K |

n/a

| -95.41% | O: 6.42% H: 0.04% C: -4.87%
AZNCF | $138.24 -4.19% 800 |

Health Technology

| 0.42% | O: -1.25% H: 0.59% C: 0.59%
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -16.88% | O: -2.47% H: 0.0% C: -0.32%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 7.56% | O: -0.25% H: 0.03% C: -0.81%
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| -11.27% | O: -0.81% H: 1.28% C: -2.05%
AZN | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 1.28% | O: -0.98% H: 0.16% C: -0.55%
research opioid market

---

Cluster Headache Market to Reach USD 522.98 Million, Globally, by 2031 at 3.9% CAGR, Claims Allied Market Research
Published: 2023-02-22 (Crawled : 16:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 13.48% | O: 0.48% H: 0.0% C: -2.77%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 7.28% | O: 0.98% H: 0.03% C: -1.06%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 10.0% | O: 0.19% H: 0.0% C: -0.91%
LLY | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 129.24% | O: 0.37% H: 1.18% C: 0.11%
research market

---

Global Medical Laser Systems Market to Reach $4.8 Billion by 2030
Published: 2023-02-10 (Crawled : 16:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 7.84% | O: -0.06% H: 0.3% C: 0.26%
IEX | $227.04 0.42% 0.0% 240K |

Producer Manufacturing

| 1.41% | O: -0.19% H: 1.37% C: 1.2%
DHR | $235.51 -0.36% 0.0% 2.3M |

Health Technology

| -5.79% | O: -0.49% H: 2.11% C: 1.96%
IRIX | $2.95 -2.32% -2.37% 50K |

Health Technology

| 24.28% | O: 0.02% H: 1.63% C: -0.43%
HOLX | $75.37 0.36% 0.36% 1.3M |

Health Technology

| -9.12% | O: -0.44% H: 0.66% C: -0.27%
CUTR | $1.95 -15.22% -17.95% 1.1M |

Health Technology

| -94.07% | O: -1.15% H: 4.95% C: 4.42%
COHR | $49.26 -3.41% 0.0% 3.3M |

Electronic Technology

| 23.78% | O: -1.12% H: 0.59% C: 0.0%
BIOL | $0.1412 -4.92% -5.17% 1.4M |

Health Technology

| -69.46% | O: 1.79% H: 3.5% C: 0.74%
ANGO | $6.26 2.29% 2.24% 480K |

Health Technology

| -49.57% | O: 0.0% H: 1.16% C: 0.39%
global medical laser market

---

The Global Antiviral Drugs Market to Exhibit Growth at a Paltry CAGR of ~4% by 2027 | DelveInsight
Published: 2023-02-02 (Crawled : 16:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 28.31% | O: -1.71% H: 0.0% C: 0.0%
VTRS | $11.25 1.17% 1.16% 4.7M |

Health Technology

| -9.3% | O: -0.16% H: 0.08% C: -0.41%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 5.5% | O: -1.87% H: 0.01% C: -0.55%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -12.11% | O: -1.16% H: 1.98% C: 1.56%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -32.19% | O: -1.28% H: 3.64% C: 3.48%
ABBV | News | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 12.66% | O: -0.46% H: 0.0% C: -0.75%
VIR | $7.96 0.0% 1.1M |

Health Technology

| -71.71% | O: 0.62% H: 2.22% C: 1.94%
TNXP | $0.159 1.27% 1.26% 1.1M |

Health Technology

| -97.81% | O: 0.85% H: 5.08% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -6.26% | O: -1.44% H: 0.0% C: 0.0%
GILD | News | $66.77 0.92% 0.91% 11M |

Health Technology

| -20.36% | O: -1.95% H: 0.16% C: -1.18%
global antiviral growth market

---

Bipolar Disorder Market is expected to generate a revenue of USD 6.27 Billion by 2030, Globally, at 2% CAGR: Verified Market Research®
Published: 2023-02-02 (Crawled : 16:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 28.31% | O: -1.71% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 5.5% | O: -1.87% H: 0.01% C: -0.55%
ABBV | News | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 12.66% | O: -0.46% H: 0.0% C: -0.75%
research expected market

---

CAR-T Cell Therapy Market Size to Reach USD 9.62 Million in 2030| Emergen Research
Published: 2023-01-09 (Crawled : 16:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K |

Health Technology

| -32.44% | O: 3.03% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 24.84% | O: 3.12% H: 0.0% C: -2.55%
ALPMY | $9.47 -1.11% 520K |

Manufacturing

| -35.94% | O: 0.58% H: 0.44% C: -0.31%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 0.86% | O: 0.76% H: 0.26% C: -3.27%
LLY | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 106.86% | O: 0.29% H: 0.27% C: -3.89%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -33.84% | O: 0.16% H: 0.05% C: -2.89%
BNTX | $86.82 0.75% 0.75% 1.6M |

Health Technology

| -42.59% | O: 1.42% H: 0.64% C: -2.27%
research car-t therapy market

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | News | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---